Stock screenerAll disclosures →
EDGAR →
TECH
Conviction 68HealthcareScan · Thu, Sep 24, 2026BIO-TECHNE Corp (TECH) closed at $72.56 (+0.06%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 64, RS Rating 83, at a 52-week high, +21.6% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
TECH$72.56+0.06%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 3.38M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price72.56
Change+0.06%
Gap+0.02%
Rel volume1.80×
Avg volume3M
Avg $ vol216.84M
SMA 2072.35
SMA 5072.19
SMA 20061.65
Price vs 50+0.51%
Price vs 200+17.69%
MA stackbullish
50/200 cross—
Supertrendup · 72.00
RSI (14)64
MACD hist-0.05
MACD cross—
Stoch %K / %D79 / 76
ADX (14)40
+DI / −DI26 / 10
RSI divergence—
MACD divergenceBullish
ATR %0.31%
ADR %0.24%
52w high72.56
52w low43.30
From 52w high+0.00%
Above 52w low+67.58%
New 52w highYes
SqueezeOn · 33d
Bollinger width0.72%
%B0.90
Donchian pos78.69%
Donchian high72.69
Donchian low72.08
AVWAP (52w high)72.56
vs AVWAP high+0.00%
AVWAP (52w low)67.34
vs AVWAP low+7.76%
OBV trendFlat
Chaikin MF (20)-0.20
Today vs 20d1.80×
Avg vol (14d)3.38M
Avg vol (20d)3M
Avg $ vol (20d)216.84M
Market cap11.38B
RS Rating83 / 99
RS 3m (vs SPY)-1.86%
RS 6m (vs SPY)+20.89%
RS line new highNo
Trend template5/8
Technical rank84.0
1 week+0.21%
1 month+0.32%
3 months+2.63%
6 months+37.71%
1 year+37.11%
YTD+21.64%
P/E155.02
P/B5.40
P/S9.36
P/FCF43.23
EPS1.16
Div yield0.44%
ROE3.48%
ROA2.84%
Debt/Eq0.01
Current4.55
EV/EBITDA31.86
Gross margin65.77%
Net margin6.04%
Rev growth-0.38%
EPS growth-56.34%
Price target73.00
Target upside0.61%
Analyst ratingHold
Institutional125.10%
Ent. value11.13B
Revenue311.42M
Net income51.05M
Gross profit208.29M
Free cash flow263.22M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out156.57M
Employees3.1K
ListedMon, May 8, 1989
Free float154.83M
Float %99.0%
Short interest5.89M
Days to cover2.5d
Short volume10.6%
Squeeze score32 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.49 vs $0.46
Last surprise+6.5% beat
Setup gradeB
Conviction68 / 100
Pattern quality—
Tech rank84.0 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance72.63
Support72.04
Days since event—
Candle confirm—
Financials as of Tue, Mar 31, 2026 · quarterly.
Recent news
- Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, GermanyPR Newswire · Wed, Sep 23, 2026
Congress activity
Disclosed STOCK Act trades in TECH · 9 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 April McClain Delaney house · D · MD · traded 2026-01-28 | Sell | $1K–$15K | 2026-01-28 | 2026-02-02 | |
April McClain Delaney house · MD · traded 2025-12-05 | Buy | $1K–$15K | 2025-12-05 | 2026-01-01 | |
April McClain Delaney house · D · MD · traded 2025-08-01 | Sell | $1K–$15K | 2025-08-01 | 2025-09-02 | |
April McClain Delaney house · D · MD · traded 2025-05-26 | Sell | $1K–$15K | 2025-05-26 | 2025-07-02 | |
 Julie Johnson house · D · TX · traded 2025-04-01 | Sell | $1K–$15K | 2025-04-01 | 2025-05-14 | |
 Rob Bresnahan house · PA · traded 2025-04-08 | Sell | $1K–$15K | 2025-04-08 | 2025-05-08 | |
April McClain Delaney house · D · MD · traded 2025-04-09 | Buy | $1K–$15K | 2025-04-09 | 2025-05-02 | |
April McClain Delaney house · D · MD · traded 2025-04-29 | Buy | $1K–$15K | 2025-04-29 | 2025-05-02 | |
Rob Bresnahan house · PA · traded 2025-02-25 | Buy | $1K–$15K | 2025-02-25 | 2025-03-27 |
Insider activity
SEC Form 4 transactions in TECH
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Crouse Steven C. President - Diag & Spatial Bi · Restricted Stock Units · 2026-08-17 | Grant | 8.7K | — | 2026-08-17 | 2026-08-19 |
Crouse Steven C. President - Diag & Spatial Bi · Restricted Stock Units · 2026-08-17 | Grant | 14.14K | — | 2026-08-17 | 2026-08-19 |
Geist William PRESIDENT, PROTEIN SCIENCES · Restricted Stock Units · 2026-08-17 | Grant | 14.76K | — | 2026-08-17 | 2026-08-19 |
Geist William PRESIDENT, PROTEIN SCIENCES · Restricted Stock Units · 2026-08-17 | Grant | 23.98K | — | 2026-08-17 | 2026-08-19 |
Herr Amy E. Director · Restricted Stock Units · 2026-08-17 | Grant | 1.38K | — | 2026-08-17 | 2026-08-19 |
Hippel James CFO · Restricted Stock Units · 2026-08-17 | Grant | 22.44K | — | 2026-08-17 | 2026-08-19 |
Hippel James CFO · Restricted Stock Units · 2026-08-17 | Grant | 36.46K | — | 2026-08-17 | 2026-08-19 |
Kelderman Kim Chief Executive Officer · Restricted Stock Units · 2026-08-17 | Grant | 57.59K | — | 2026-08-17 | 2026-08-19 |
Kelderman Kim Chief Executive Officer · Restricted Stock Units · 2026-08-17 | Grant | 93.58K | — | 2026-08-17 | 2026-08-19 |
Bohnen Shane SVP - General Counsel · Restricted Stock Units · 2026-08-17 | Grant | 11.34K | — | 2026-08-17 | 2026-08-19 |
SEC filings
EDGAR filings in TECH · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.